Windward Bio
PrivateLast Round
Series A
Jan 10, 2025
Total Funding Raised
$200M
Company Overview
Windward Bio is a biotechnology company that is a clinical-stage drug developer of treatments for people living with advanced immunological diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Windward Bio Comparables
Compare Windward Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Uniquity Bio | 94% | |
| Belenos Biosciences Inc. | 85% | |
| Upstream Bio | 85% |
Windward Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 10, 2025 |
Windward Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Omega Funds | Series A |
| Blue Owl Capital | Series A |
| OrbiMed | Series A |
| Pivotal bioVenture Partners | Series A |
| Novo Holdings | Series A |
| SR One | Series A |
| Quan Capital | Series A |
Windward Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Windward Bio's valuation, stock price, and market status.
Is Windward Bio a public or private company?
Windward Bio is a private company.
What is the current stock price of Windward Bio?
Windward Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Windward Bio worth (valuation)?
Valuation information for Windward Bio is not publicly available.
Can I buy Windward Bio stock?
Windward Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Windward Bio's last funding round?
Windward Bio's most recent funding round was Series A on January 10, 2025.
Who are the main investors in Windward Bio?
Key investors in Windward Bio include Blue Owl Capital, OrbiMed, Novo Holdings.
Will Windward Bio IPO soon?
No public IPO plans have been announced for Windward Bio.
How can I track Windward Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Windward Bio's secondary market activity and sign up for updates.